FDA Inspection 968469 — Eversight Illinois, Bloomington
The FDA completed an inspection of Eversight Illinois, Bloomington on Apr 14, 2016 in Bloomington, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 14, 2016
- Fiscal Year
- 2016
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Bloomington, IL (United States)